Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.

Health Diagnostics

Health Care

Biotechnology

Personalis

Christopher Hall

Ken Brunt

Yuker Wang

Dr. Twinkal Marfatia

Dan Norton

Stephen Fairclough

Deepshikha Bhandari

Gail Stanley

Aaron Tachibana

Stephen Moore

Stephane Mouradian

Richard Chen

James Azzaro

The Biopharma Business Development team at Personalis is responsible for establishing and nurturing partnerships with biopharmaceutical companies. This team leverages Personalis' advanced sequencing technologies and comprehensive molecular data capabilities to offer tailored solutions that support the development of next-generation cancer therapies. Their focus includes identifying strategic collaboration opportunities, driving business growth, and expanding the company's footprint in oncology research and biopharma collaborations globally.

Biopharma Business Development

Scientific and Medical Team

Bioinformatics and Software Engineering Team

Biopharma Business Development

About

Team members

Other teams at Personalis

Scientific and Medical Team

Bioinformatics and Software Engineering Team